Brief: ASIT Biotech Initiates Search For Strategic Commercial Partner For Future Marketing Of GP-ASIT+

European Medical Solutions SA

05/11/2018 07:24

Nov 5 (Reuters) - ASIT BIOTECH SA  ASIT.BR :
    * ASIT BIOTECH INITIATES SEARCH FOR A STRATEGIC COMMERCIAL
PARTNER
FOR FUTURE MARKETING OF GP-ASIT+, ITS PHASE III PRODUCT
CANDIDATE TO PREVENT GRASS POLLEN INDUCED ALLERGIC RHINITIS
    * SAGE GROUP HAS BEEN APPOINTED TO IDENTIFY A COMMERCIAL
PARTNER
WITH A SPECIAL FOCUS ON THE US MARKET
    * ASIT BIOTECH IS MEETING POTENTIAL PARTNERS AT THE
BIO-EUROPE
2018 PARTNERING CONFERENCE IN COPENHAGEN THIS WEEK
    * CURRENTLY PREPARING CONFIRMATORY PHASE III STUDY IN ABOUT
600
PATIENTS WITH SCREENING EXPECTED TO BEGIN IN EARLY 2019 IN ORDER
TO TREAT ALL PATIENTS BEFORE START OF 2019 POLLEN SEASON
    * A FUTURE PARTNER COULD ALSO POTENTIALLY ACCESS THE ASIT
BIOTECH
IMMUNOTHERAPY PIPELINE FOR FOOD AND HOUSE DUST MITE ALLERGIES,
CURRENTLY IN PRECLINICAL DEVELOPMENT.
    * DEVELOPED INNOVATIVE IMMUNOTHERAPY PRODUCT ENTERING
CONFIRMATORY
PHASE III STUDY IN GRASS POLLEN INDUCED ALLERGIC RHINITIS,
REQUIRING ONLY 3-WEEK TREATMENT COURSE PRIOR TO POLLEN SEASON

Source text: https://bit.ly/2OpMiUs
Further company coverage:  ASIT.BR 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))